je.st
news
Home
› Incyte Announces Top-Line Results From RELIEF Trial Of Ruxolitinib In Patients With Polycythemia Vera
Incyte Announces Top-Line Results From RELIEF Trial Of Ruxolitinib In Patients With Polycythemia Vera
2014-07-30 09:39:10| drugdiscoveryonline Home Page
Incyte Corporation recently announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV) treated with ruxolitinib versus patients treated with hydroxyurea (HU)
Tags: with
results
trial
patients
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||